Table 4.
Variable | Model 1 aHR (95% CI) | p | Model 2 aHR (95% CI) | P |
---|---|---|---|---|
no-CKD | ||||
no-AKI | Reference | Reference | ||
AKI 1 | 2.11 (1.33–3.35) | 0.001 | 2.13 (1.34–3.37) | 0.001 |
AKI ≥2 | 2.72 (1.74–4.25) | <0.001 | 2.79 (1.79–4.34) | <0.001 |
CKD | ||||
no-AKI | 0.92 (0.54–1.58) | 0.769 | 0.94 (0.55–1.61) | 0.835 |
AKI 1 | 0.95 (0.54–1.67) | 0.863 | 0.96 (0.54–1.68) | 0.878 |
AKI ≥2 | 2.21 (1.35–3.64) | 0.002 | 2.33 (1.43–3.80) | <0.001 |
Age, per 1 yr | 1.01 (1.00–1.02) | 0.093 | 1.01 (1.00–1.02) | 0.112 |
African American | 1.28 (0.97–1.71) | 0.083 | 1.28 (0.96–1.70) | 0.087 |
Male gender | 0.98 (0.74–1.30) | 0.880 | 0.98 (0.74–1.29) | 0.867 |
Diabetes | 0.98 (0.71–1.36) | 0.924 | 0.98 (0.71–1.36) | 0.921 |
Systolic heart failure | 0.85 (0.40–1.82) | 0.678 | — | |
Anemia | 1.87 (1.10–3.18) | 0.021 | 1.88 (1.11–3.19) | 0.019 |
Nonrenal SOFA ≥4 | 1.57 (1.14–2.15) | 0.005 | 1.48 (1.11–1.98) | 0.008 |
Mechanical ventilation | 0.83 (0.60–1.15) | 0.259 | — | |
RBC transfusion | 0.87 (0.35–2.13) | 0.760 | — | |
LOS, per 1 d | 1.11 (0.81–1.51) | 0.505 | — | |
Exposure to statins | 0.93 (0.69–1.27) | 0.671 | — |
APACHE II score was not included in the models due to collinearity with the SOFA score; aHR, adjusted hazard ratio; AKI, acute kidney injury; APACHE II, Acute Physiology and Chronic Health Evaluation II; CI, confidence interval; CKD, chronic kidney disease; LOS, length of stay in the hospital; RBC, red blood cells; SOFA, Sequential Organ Failure Assessment.
Data are aHRs and 95% CIs for incident/progressive CKD by Cox proportional hazard regression. Model 1 included all tested variables, while model 2 includes variables of deemed particular clinical relevance (age, race, gender, diabetes), together with additional variables that were retained through backward selection (cut-off for retention: P < 0.10).